Advertisement
Screener

Axogen, Inc. (AXGN) Graph

AXGN Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-30: Revenue $69.73M; Cost of revenue $19.06M; Research and development $8.59M; Income tax $0.00.
  • 2026-03-31: Revenue $61.46M; Cost of revenue $15.27M; Research and development $7.52M; Income tax $0.00.
  • 2025-12-31: Revenue $59.90M*; Cost of revenue $15.49M*; Research and development $12.38M*; Income tax $0.00*.
  • 2025-09-30: Revenue $60.08M; Cost of revenue $14.09M; Research and development $7.57M; Income tax $0.00.

Geography

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

AXGN revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Non Us$726.00KUS$69.00MRevenue$69.73MCost of revenue$19.06MGross profit$50.67MOperating income-$2.16MOther income, net-$145.00KResearch & development$8.59MIncome tax$0.00Net income-$1.52M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueCost of revenueResearch and developmentIncome taxNet income
2026-06-30$69.73M$19.06M$8.59M$0.00-$1.52M
2026-03-31$61.46M$15.27M$7.52M$0.00-$19.58M
2025-12-31$59.90M*$15.49M*$12.38M*$0.00*-$13.16M*
2025-09-30$60.08M$14.09M$7.57M$0.00$708.00K
2025-06-30$56.66M$14.64M$6.85M$0.00$579.00K
2025-03-31$48.56M$13.63M$6.09M$0.00-$3.83M
2024-09-30$48.64M$12.21M$7.00M$0.00-$1.86M
2024-06-30$47.91M$12.57M$6.66M$0.00-$1.92M
2024-03-31$41.38M$8.76M$7.41M$0.00-$6.63M
2023-09-30$41.27M$9.57M$6.69M(m)-$4.09M
2023-06-30$38.16M$8.50M$7.14M(m)-$6.66M
2023-03-31$36.66M$8.17M$6.33M(m)-$7.07M
2022-09-30$36.96M$6.18M$7.05M(m)-$4.32M
2022-06-30$34.45M$6.28M$7.02M(m)-$7.74M
2022-03-31$31.01M$5.55M$6.28M(m)-$11.47M
2021-09-30$31.20M$5.24M$6.40M(m)-$7.14M
2021-06-30$33.58M$7.09M$5.72M(m)-$7.90M
2021-03-31$31.04M$5.17M$5.75M(m)-$6.66M
2020-12-31$32.49M(m)(m)(m)-$6.01M
2020-09-30$33.43M$5.70M$4.23M(m)-$1.48M
2020-06-30$22.12M$5.61M$4.07M(m)-$8.11M
2020-03-31$24.26M$4.82M$4.61M(m)-$8.19M
2019-12-31$28.16M(m)(m)(m)-$7.04M
2019-09-30$28.56M$4.51M$4.18M(m)-$5.57M
2019-06-30$26.70M$4.24M$4.28M(m)-$7.02M
2019-03-31$23.29M$3.71M$4.14M(m)-$9.50M
2018-12-31$23.43M(m)(m)(m)-$5.22M
2018-09-30$22.66M$3.46M$3.31M(m)-$4.10M
2018-06-30$20.58M$3.11M$2.60M(m)-$7.43M
2018-03-31$17.26M$2.71M$2.06M(m)-$5.64M
2017-12-31$16.97M(m)(m)(m)-$2.50M
2017-09-30$16.05M(m)$1.80M(m)-$2.12M
2017-06-30$15.17M(m)$1.52M(m)-$2.06M
2017-03-31$12.24M(m)$1.41M(m)-$3.76M
2016-12-31$11.41M(m)(m)(m)-$5.63M
2016-09-30$11.21M(m)$1.12M(m)-$2.31M
2016-06-30$10.38M(m)$936.82K(m)-$2.80M
2016-03-31$8.11M(m)$978.34K(m)-$3.68M
2015-09-30$8.15M(m)$936.01K(m)-$2.98M
2015-06-30$6.42M(m)$736.40K(m)-$3.19M
2015-03-31$4.95M(m)$671.04K(m)-$3.58M
2014-09-30$4.67M(m)$681.23K(m)-$3.24M
2014-06-30$4.21M(m)$555.76K(m)-$3.74M
2014-03-31$3.14M(m)$812.62K(m)-$4.24M
2013-09-30$2.96M(m)$593.64K$0.00-$3.55M
2013-06-30$2.86M(m)$498.32K(m)-$3.46M
2013-03-31$2.14M(m)$406.94K(m)-$3.44M
2012-09-30$1.98M(m)$390.39K$0.00-$2.24M
2012-06-30$2.01M(m)$367.36K-$736.43K-$1.03M
2012-03-31$1.65M(m)$296.13K(m)-$2.11M
2011-09-30$1.14M(m)$229.71K(m)-$3.11M
2011-06-30$1.23M(m)$101.12K$286.50K-$1.68M
2011-03-31$1.12M(m)$105.59K(m)-$2.29M
2010-09-30$800.74K(m)$36.17K(m)-$943.36K
2010-06-30$3.25K(m)(m)-$104.00K-$230.39K

Revenue and expense 6 month

Period endRevenueCost of revenueResearch and developmentIncome taxNet income
2026-06-30$131.19M$34.33M$16.11M$0.00-$21.10M
2025-06-30$105.22M$28.27M$12.94M$0.00-$3.25M
2024-06-30$89.29M$21.32M$14.07M$0.00-$8.56M
2023-06-30$74.82M$16.68M$13.47M(m)-$13.73M
2022-06-30$65.46M$11.83M$13.30M(m)-$19.21M
2021-06-30$64.62M$12.26M$11.47M(m)-$14.56M
2020-06-30$46.38M$10.42M$8.69M(m)-$16.30M
2019-06-30$49.99M$7.96M$8.42M(m)-$16.53M
2018-06-30$37.84M$5.82M$4.66M(m)-$13.07M
2017-06-30$27.41M(m)$2.93M(m)-$5.82M
2016-06-30$18.49M(m)$1.92M(m)-$6.48M
2015-06-30$11.37M(m)$1.41M(m)-$6.77M
2014-06-30$7.35M(m)$1.37M(m)-$7.98M
2013-06-30$5.01M(m)$905.26K(m)-$6.90M
2012-06-30$3.67M(m)$663.49K-$736.43K-$3.14M
2011-06-30$2.35M(m)$206.71K$870.00K-$3.97M
2010-06-30$22.78K(m)(m)-$229.00K-$476.32K

Revenue and expense 9 month

Period endRevenueCost of revenueResearch and developmentIncome taxNet income
2025-09-30$165.30M$42.36M$20.51M$0.00-$2.55M
2024-09-30$137.93M$33.53M$21.06M$0.00-$10.41M
2023-09-30$116.09M$26.24M$20.16M(m)-$17.82M
2022-09-30$102.42M$18.01M$20.35M(m)-$23.53M
2021-09-30$95.82M$17.50M$17.88M(m)-$21.70M
2020-09-30$79.81M$16.12M$12.91M(m)-$17.78M
2019-09-30$78.55M$12.47M$12.60M(m)-$22.10M
2018-09-30$60.50M$9.28M$7.97M(m)-$17.17M
2017-09-30$43.46M(m)$4.73M(m)-$7.95M
2016-09-30$29.70M(m)$3.03M(m)-$8.78M
2015-09-30$19.52M(m)$2.34M(m)-$9.74M
2014-09-30$12.02M(m)$2.05M(m)-$11.22M
2013-09-30$7.96M(m)$1.50M$0.00-$10.45M
2012-09-30$5.65M(m)$1.05M-$736.43K-$5.38M
2011-09-30$3.49M(m)$436.42K(m)-$7.08M
2010-09-30$2.20M(m)$75.45K(m)-$2.64M

Revenue and expense 12 month

Period endRevenueCost of revenueResearch and developmentIncome taxNet income
2025-12-31$225.21M$57.85M$32.88M$0.00-$15.70M
2024-12-31$187.34M$45.36M$27.77M$0.00-$9.96M
2023-12-31$159.01M$37.14M$27.34M$0.00-$21.72M
2022-12-31$138.58M$29.77M$25.63M$0.00-$28.95M
2021-12-31$127.36M$22.93M$24.18M$0.00-$26.98M
2020-12-31$112.30M$21.58M$17.85M$0.00-$23.79M
2019-12-31$106.71M$17.35M$17.51M$0.00-$29.14M
2018-12-31$83.94M$12.92M$11.77M$0.00-$22.40M
2017-12-31$60.43M$9.31M$6.70M$0.00-$10.45M
2016-12-31$41.11M$6.47M$4.21M$0.00-$14.41M
2015-12-31$27.33M(m)$3.24M$0.00-$13.36M
2014-12-31$16.82M(m)$3.03M$0.00-$17.71M
2013-12-31$10.95M(m)$2.13M$0.00-$14.56M
2012-12-31$7.69M(m)$1.43M-$738.19K-$9.42M
2011-12-31$4.85M(m)$697.36K(m)-$9.22M
2010-12-31$3.00M(m)$436.01K(m)-$5.42M

Similar stocks

Stock NameCountryMarket CapPE Ratio
BIOLIFE SOLUTIONS INC (BLFS)United States$1.887B23.80
TransMedics Group, Inc. (TMDX)United States$2.911B15.17
CONMED Corp (CNMD)United States$1.353B26.72
Ceribell, Inc. (CBLL)United States$0.916B-11.27
LivaNova PLC (LIVN)$4.158B24.01
Integer Holdings Corp (ITGR)United States$4.289B25.17
CapsoVision, Inc (CV)United States$0.310B-12.68
Electromed, Inc. (ELMD)United States$0.233B31.13
EDAP TMS SA (FOCL)$0.171B
Stereotaxis, Inc. (STXS)United States$0.130B-7.53